Caramel A, Schnetz K
Institut für Genetik, der Universität zu Köln, Weyertal 121, D-50931 Köln, Germany.
Mol Microbiol. 2000 Apr;36(1):85-92. doi: 10.1046/j.1365-2958.2000.01827.x.
The wild-type Escherichia coli bgl promoter is silent in vivo but active in vitro. Silencing in vivo is directed by silencer sequences that flank the promoter, and requires nucleoid-associated protein H-NS and other unidentified cellular factors. Here we show that the DNA bending protein FIS is a repressor of the bgl promoter. Two FIS binding sites, centred at positions -52 and -27, overlap the CAP binding site and the -35 box respectively. FIS efficiently competes with CAP for binding to the wild-type promoter. However, FIS does not prevent binding of RNA polymerase. It interferes with the formation of a heparin-resistant complex and represses transcription initiation up to 40-fold. The presence of CAP has very little effect on the FIS-mediated repression of the wild-type bgl promoter in vitro. However, when a bgl promoter allele was tested that carries an improved CAP binding site (which leads to activation in vivo) CAP effectively counteracted repression by FIS in vitro. These results suggest that FIS contributes to silencing of the wild-type bgl promoter in vivo, presumably in the early exponential phase when FIS is predominantly expressed.
野生型大肠杆菌bgl启动子在体内是沉默的,但在体外具有活性。体内沉默是由启动子两侧的沉默子序列指导的,并且需要类核相关蛋白H-NS和其他未鉴定的细胞因子。在这里,我们表明DNA弯曲蛋白FIS是bgl启动子的阻遏物。两个FIS结合位点,分别位于-52和-27位置,分别与CAP结合位点和-35框重叠。FIS能有效地与CAP竞争结合野生型启动子。然而,FIS并不阻止RNA聚合酶的结合。它干扰了抗肝素复合物的形成,并将转录起始抑制高达40倍。CAP的存在对体外FIS介导的野生型bgl启动子的抑制作用影响很小。然而,当测试携带改进的CAP结合位点(这导致体内激活)的bgl启动子等位基因时,CAP在体外有效地抵消了FIS的抑制作用。这些结果表明,FIS在体内有助于野生型bgl启动子的沉默,推测是在FIS主要表达的指数早期阶段。